Michael Edward Szperka

Array ( [id] => 20295042 [patent_doc_number] => 20250320285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-16 [patent_title] => ALBUMIN BINDING PROTEINS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 19/180749 [patent_app_country] => US [patent_app_date] => 2025-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19180749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20150490 [patent_doc_number] => 20250250328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-07 [patent_title] => Antigen Binding Proteins [patent_app_type] => utility [patent_app_number] => 19/086720 [patent_app_country] => US [patent_app_date] => 2025-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19086720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20067062 [patent_doc_number] => 20250205284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => PLATELET DERIVATIVE COMPOSITIONS, AND PLURALITIES OF CONTAINERS CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 19/074158 [patent_app_country] => US [patent_app_date] => 2025-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71773 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19074158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20402296 [patent_doc_number] => 12492265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Anti-IgE antibody therapy for multiple food allergies [patent_app_type] => utility [patent_app_number] => 19/050002 [patent_app_country] => US [patent_app_date] => 2025-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20364 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19050002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20240992 [patent_doc_number] => 12421300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-23 [patent_title] => Preparation method and application of single-chain antibody fragment targeting SARS-CoV-2 nucleocapsid protein [patent_app_type] => utility [patent_app_number] => 18/951667 [patent_app_country] => US [patent_app_date] => 2024-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 1780 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18951667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19800558 [patent_doc_number] => 20250066483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => ANTI-PD-L1 ANTIBODY, ANTI-PD-1 ANTIBODY, AND THE USE OF INHIBITOR TARGETING PD-1/PD-L1 AND COX-2 INHIBITOR [patent_app_type] => utility [patent_app_number] => 18/914727 [patent_app_country] => US [patent_app_date] => 2024-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18914727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19629692 [patent_doc_number] => 20240408141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING A SUBJECT TAKING AN ANTI-PLATELET AGENT [patent_app_type] => utility [patent_app_number] => 18/810381 [patent_app_country] => US [patent_app_date] => 2024-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74949 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18810381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19543170 [patent_doc_number] => 20240360206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => PHOSPHO-TAU ANTIBODIES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/770102 [patent_app_country] => US [patent_app_date] => 2024-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30252 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18770102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19418497 [patent_doc_number] => 20240294620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODIFIED IMMUNOGLOBULINS FOR TARGETING AMYLOID DEPOSITS [patent_app_type] => utility [patent_app_number] => 18/660156 [patent_app_country] => US [patent_app_date] => 2024-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53299 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19418498 [patent_doc_number] => 20240294621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODIFIED IMMUNOGLOBULINS FOR TARGETING AMYLOID DEPOSITS [patent_app_type] => utility [patent_app_number] => 18/660162 [patent_app_country] => US [patent_app_date] => 2024-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20287183 [patent_doc_number] => 20250312426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => NOVEL COMPOSITIONS AND USES THEREOF FOR PRODUCTION OF ALLERGEN TOLERANCE [patent_app_type] => utility [patent_app_number] => 18/626462 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 992 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20240980 [patent_doc_number] => 12421288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-23 [patent_title] => Interferon alpha-2 variants [patent_app_type] => utility [patent_app_number] => 18/607194 [patent_app_country] => US [patent_app_date] => 2024-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 31403 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18607194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19529526 [patent_doc_number] => 20240353428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => PHOSPHO-TAU ANTIBODIES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/599751 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30237 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18599751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19403696 [patent_doc_number] => 20240287207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => PROCESS FOR IMPROVING POLYPEPTIDE EXPRESSION IN MAMMALIAN CELL CULTURE [patent_app_type] => utility [patent_app_number] => 18/429203 [patent_app_country] => US [patent_app_date] => 2024-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18429203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19608897 [patent_doc_number] => 12157763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Antibody specific to spike protein of SARS-CoV-2 and uses thereof [patent_app_type] => utility [patent_app_number] => 18/403419 [patent_app_country] => US [patent_app_date] => 2024-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 9472 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18403419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20024963 [patent_doc_number] => 20250163185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => Method for Primary Prevention of Allergic Disorders During Infancy Through IgE-Class-Specific Immunosuppression [patent_app_type] => utility [patent_app_number] => 18/516127 [patent_app_country] => US [patent_app_date] => 2023-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13638 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18516127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19187815 [patent_doc_number] => 20240166728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => ANTIGEN BINDING PROTEINS [patent_app_type] => utility [patent_app_number] => 18/498114 [patent_app_country] => US [patent_app_date] => 2023-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34176 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18498114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19291612 [patent_doc_number] => 12030959 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-07-09 [patent_title] => Anti-IgE antibody therapy for multiple food allergies [patent_app_type] => utility [patent_app_number] => 18/486053 [patent_app_country] => US [patent_app_date] => 2023-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 24213 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18486053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19083155 [patent_doc_number] => 20240109956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => RAPID ELICITATION OF BROADLY NEUTRALIZING BOVINE ANTIBODIES TO HIV ENV [patent_app_type] => utility [patent_app_number] => 18/470044 [patent_app_country] => US [patent_app_date] => 2023-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73953 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18861968 [patent_doc_number] => 20230416404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => FACTOR X BINDERS ENHANCING FX ACTIVATION [patent_app_type] => utility [patent_app_number] => 18/242868 [patent_app_country] => US [patent_app_date] => 2023-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18242868 [rel_patent_id] =>[rel_patent_doc_number] =>)